在接受甲福明的阻塞性睡眠呼吸暂停患者中,高乳糖血的风险:一个横截面研究
Aleksander Kania1, Kamil Polok2,3, Natalia Celejewska-Wójcik2
1Department of Internal Medicine, Faculty of Medicine, Jagiellonian University Medical College, Jakubowskiego 2, Krakow, 30-688, Poland. aleksander.1.kania@uj.edu.pl.
Sleep & breathing = Schlaf & Atmung
|October 7, 2025
概括
在患有阻塞性睡眠呼吸暂停 (OSA) 的2型糖尿病患者中使用甲福明对乳酸代谢是安全的. 然而,活跃吸烟会增加这些接受甲福林治疗的患者的高乳糖血症风险.
科学领域:
- 内分泌学 在内分泌学.
- 肺部病理学 肺部病理学
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 2型糖尿病和阻塞性睡眠呼吸暂停 (OSA) 经常同时存在.
- 甲胺是一种常见的2型糖尿病药物,可以提高乳酸水平.
- OSA可能会增加高乳糖血症的风险,因此需要对甲福明在这种情况下的影响进行调查.
研究的目的:
- 确定影响2型糖尿病和OSA患者血清乳酸盐度的因素.
- 评估这一患者群体中乳糖过高的风险,特别是关于甲福明的使用和OSA严重性的风险.
主要方法:
- 评估了505名患有2型糖尿病和OSA的患者队列.
- 对所有参与者进行了诊断性夜间多眠学.
- 测量了血清乳酸水平,并分析了与甲福林使用,吸烟和OSA严重性的关联.
主要成果:
- 乳酸盐度中位数为1.0mmol/L,根据OSA的严重程度没有显著差异.
- 与非使用者相比,使用甲福明的患者的乳酸盐度较高 (p < 0.001).
- 超乳糖血症与甲胺使用 (p < 0.001) 和活跃吸烟 (p = 0.014) 有关.
结论:
- 无论OSA的严重程度如何,在患有OSA的2型糖尿病患者中,对乳酸代谢而言,梅特福林的使用似乎是安全的.
- 活跃吸烟是甲福林治疗OSA和2型糖尿病患者高乳糖血症的重要危险因素.
- 建议针对这一高风险小组,针对戒烟的有针对性的干预措施.
相关概念视频
Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...


